Efficacy of galcanezumab in patients with migraine and history of failure to 3–4 preventive medication categories: subgroup analysis from CONQUER study

BACKGROUND: Chronic migraine (CM) and episodic migraine (EM) are associated with substantial headache-related disability, poor quality of life and global societal burden. In this subgroup analysis from the CONQUER study, we report efficacy outcomes from a pre-specified analysis of galcanezumab versu...

Descripción completa

Detalles Bibliográficos
Autores principales: Okonkwo, Rose, Tockhorn-Heidenreich, Antje, Stroud, Chad, Paget, Marie-Ange, Matharu, Manjit S., Tassorelli, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482748/
https://www.ncbi.nlm.nih.gov/pubmed/34592919
http://dx.doi.org/10.1186/s10194-021-01322-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482748/
https://www.ncbi.nlm.nih.gov/pubmed/34592919
http://dx.doi.org/10.1186/s10194-021-01322-7

Ejemplares similares